|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/209 | (2013.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/2031 | (2013.01) | ||
| A61K 31/4725 | (2013.01) | ||
| A61K 31/18 | (2013.01) |
| (11) | Number of the document | 4255398 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21819877.8 |
| Date of filing the European patent application | 2021-11-30 | |
| (97) | Date of publication of the European application | 2023-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2021/083654 |
| Date | 2021-11-30 |
| (87) | Number | WO 2022/117594 |
| Date | 2022-06-09 |
| (30) | Number | Date | Country code |
| 20211022 | 2020-12-01 | EP |
| (72) |
BOLTROMIUK, Tomasz , PL
|
| (73) |
Adamed Pharma S.A. ,
Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow,
PL
Adalvo Limited , Malta Life Science Park Building 1 Level 4, San Gwann, SGN 3000, MT |
| (54) | ORALLY-ADMINISTERED PREPARATION CONTAINING SOLIFENACIN AND TAMSULOSIN |
| ORALLY-ADMINISTERED PREPARATION CONTAINING SOLIFENACIN AND TAMSULOSIN |